Adia Nutrition, Inc. (ADIA): R&D Expense

Annual figures by period end, from SEC filings.

$29.1K

Year ended 2025-12-31

$4.5K

Trailing 12 months to 2026-06-30

2024-12-31 R&D Expense (USD) 2025-12-31

Period ended	R&D Expense	Change YoY	Source filing
2025-12-31	$29.1K	n/a	2026-03-31, From 2025-01-01
2024-12-31	$0	n/a	2026-03-31, From 2024-01-01

R&D Expense at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	R&D Expense	Change YoY
Adia Nutrition, Inc. (ADIA)	2025-12-31	$29.1K	n/a
Bon Natural Life Ltd (BON)	2025-09-30	$754.2K	-53.5%
Cyanotech Corp (CYAN)	2025-03-31	$449.0K	-34.8%
Leef Brands Inc. (LEEEF)	2025-12-31	$19.7K	+3.8%
Mannatech Inc (MTEX)	2025-12-31	$800.0K	+14.3%
Niagen Bioscience, Inc. (NAGE)	2025-12-31	$6.33M	+5.2%
Natural Alternatives International Inc (NAII)	2025-06-30	$1.80M	-5.3%
Cronos Group Inc. (CRON)	2025-12-31	$4.45M	+5.2%
Tilray Brands, Inc. (TLRY)	2026-05-31	$361.0K	+27.1%

Compare ADIA, BON, CYAN, LEEEF side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗